speb/financial-data huggingface dataset:
CVX income_statement (annual, 2022-12-31) — Net Interest Income: -516000000.00
CVX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 117000000.00
CVX cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -8479000000.00
CVX cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -8742000000.00
CVX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -516000000.00
CVX cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -114000000.00
CVX cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 1411000000.00
CVX balance_sheet (annual, 2022-12-31) — Net PPE: 143591000000.00
CVX cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 263000000.00
CVX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 154560000000.00
CVX balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 1069000000.00
CVX balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 12310000000.00
CVX balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 17131000000.00
CVX balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 20396000000.00
CVX balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 17131000000.00
CVX income_statement (annual, 2022-12-31) — Normalized EBITDA: 65485000000.00
CVX income_statement (annual, 2022-12-31) — Normalized Income: 35465000000.00
CVX cash_flow (annual, 2022-12-31) — Operating Cash Flow: 49602000000.00
CVX cash_flow (annual, 2022-12-31) — Operating Gains Losses: -8997000000.00
CVX income_statement (annual, 2022-12-31) — Operating Income: 39950000000.00
CVX income_statement (annual, 2022-12-31) — Operating Revenue: 235717000000.00
CVX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 1901048343.00
CVX balance_sheet (annual, 2022-12-31) — Other Current Assets: 3739000000.00
CVX balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 1919000000.00
CVX balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -12000000.00
CVX income_statement (annual, 2022-12-31) — Other Income Expense: 10240000000.00
CVX cash_flow (annual, 2022-12-31) — Other Non Cash Items: -1299000000.00
CVX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 12746000000.00
CVX balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 20396000000.00
CVX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 1655000000.00
CVX income_statement (annual, 2022-12-31) — Other Operating Expenses: 25688000000.00
CVX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 223000000.00
CVX income_statement (annual, 2022-12-31) — Other Taxes: 4032000000.00
CVX balance_sheet (annual, 2022-12-31) — Payables: 24758000000.00
CVX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 32244000000.00
CVX balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CVX balance_sheet (annual, 2022-12-31) — Prepaid Assets: 3739000000.00
CVX income_statement (annual, 2022-12-31) — Pretax Income: 49674000000.00
CVX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 5838000000.00
CVX cash_flow (annual, 2022-12-31) — Purchase Of Business: -2862000000.00
CVX cash_flow (annual, 2022-12-31) — Purchase Of Investment: -7000000.00
CVX balance_sheet (annual, 2022-12-31) — Raw Materials: 1866000000.00
CVX balance_sheet (annual, 2022-12-31) — Receivables: 20456000000.00
CVX income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 161735000000.00
CVX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 15295000000.00
CVX cash_flow (annual, 2022-12-31) — Repayment Of Debt: -8742000000.00
CVX cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -11255000000.00
CVX balance_sheet (annual, 2022-12-31) — Retained Earnings: 190024000000.00
CVX cash_flow (annual, 2022-12-31) — Sale Of Business: 1200000000.00
CVX cash_flow (annual, 2022-12-31) — Sale Of Investment: 124000000.00
CVX income_statement (annual, 2022-12-31) — Selling General And Administration: 4312000000.00
CVX balance_sheet (annual, 2022-12-31) — Share Issued: 2442676580.00
CVX cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 263000000.00
CVX cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
CVX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 159282000000.00
CVX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 154560000000.00
CVX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CVX income_statement (annual, 2022-12-31) — Tax Provision: 14066000000.00
CVX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.28
CVX balance_sheet (annual, 2022-12-31) — Total Assets: 257709000000.00
CVX balance_sheet (annual, 2022-12-31) — Total Capitalization: 180254000000.00
CVX balance_sheet (annual, 2022-12-31) — Total Debt: 23339000000.00
CVX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 160242000000.00
CVX income_statement (annual, 2022-12-31) — Total Expenses: 195767000000.00
CVX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 97467000000.00
CVX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 207366000000.00
CVX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 63259000000.00
CVX balance_sheet (annual, 2022-12-31) — Total Tax Payable: 5803000000.00
CVX balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 541628237.00
CVX balance_sheet (annual, 2022-12-31) — Treasury Stock: 48196000000.00
CVX balance_sheet (annual, 2022-12-31) — Unrealized Gain Loss: -12000000.00
CVX balance_sheet (annual, 2022-12-31) — Working Capital: 16135000000.00
CVX income_statement (annual, 2023-12-31) — +Operating Expense: 34162000000.00
CVX income_statement (annual, 2023-12-31) — +Total Revenue: 196913000000.00
CVX balance_sheet (annual, 2023-12-31) — Accounts Payable: 20423000000.00
CVX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 19921000000.00
CVX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -192462000000.00
CVX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 21365000000.00
CVX balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -301000000.00
CVX cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 2180000000.00
CVX income_statement (annual, 2023-12-31) — Basic Average Shares: 1872737000.00
CVX income_statement (annual, 2023-12-31) — Basic EPS: 11.41
CVX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 19121000000.00
CVX cash_flow (annual, 2023-12-31) — Capital Expenditure: -15829000000.00
CVX cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -15829000000.00
CVX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 634000000.00
CVX balance_sheet (annual, 2023-12-31) — Capital Stock: 1832000000.00
CVX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 8178000000.00
CVX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 8223000000.00
CVX cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -11336000000.00
CVX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -30109000000.00
CVX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -15232000000.00
CVX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 35609000000.00
CVX cash_flow (annual, 2023-12-31) — Change In Account Payable: -49000000.00
CVX cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: -2801000000.00
CVX cash_flow (annual, 2023-12-31) — Change In Inventory: -320000000.00
CVX cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -300000000.00
CVX cash_flow (annual, 2023-12-31) — Change In Payable: -2850000000.00
CVX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -2850000000.00
CVX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -1202000000.00
CVX cash_flow (annual, 2023-12-31) — Change In Receivables: 1337000000.00
CVX cash_flow (annual, 2023-12-31) — Change In Tax Payable: -2801000000.00
CVX cash_flow (annual, 2023-12-31) — Change In Working Capital: -3335000000.00
CVX cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 1187000000.00
CVX cash_flow (annual, 2023-12-31) — Changes In Cash: -9732000000.00
CVX balance_sheet (annual, 2023-12-31) — Common Stock: 1832000000.00
CVX cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -11336000000.00
CVX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 160957000000.00
CVX cash_flow (annual, 2023-12-31) — Common Stock Payments: -14939000000.00
CVX income_statement (annual, 2023-12-31) — Cost Of Revenue: 136522000000.00
CVX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 7655000000.00
CVX balance_sheet (annual, 2023-12-31) — Current Assets: 41128000000.00
CVX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 60000000.00
CVX balance_sheet (annual, 2023-12-31) — Current Debt: 469000000.00
CVX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 529000000.00
CVX balance_sheet (annual, 2023-12-31) — Current Liabilities: 32258000000.00
CVX cash_flow (annual, 2023-12-31) — Deferred Income Tax: 298000000.00
CVX cash_flow (annual, 2023-12-31) — Deferred Tax: 298000000.00
CVX cash_flow (annual, 2023-12-31) — Depletion: 436000000.00
CVX cash_flow (annual, 2023-12-31) — Depreciation: 17326000000.00
CVX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 17762000000.00
CVX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 17326000000.00
CVX income_statement (annual, 2023-12-31) — Diluted Average Shares: 1880307000.00
CVX income_statement (annual, 2023-12-31) — Diluted EPS: 11.36
CVX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 21369000000.00
CVX cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 4246000000.00
CVX income_statement (annual, 2023-12-31) — EBIT: 30053000000.00
CVX income_statement (annual, 2023-12-31) — EBITDA: 47815000000.00
CVX income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 5131000000.00
CVX cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: -5131000000.00
CVX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -114000000.00
CVX balance_sheet (annual, 2023-12-31) — Employee Benefits: 4082000000.00
CVX cash_flow (annual, 2023-12-31) — End Cash Position: 9275000000.00
CVX cash_flow (annual, 2023-12-31) — Financing Cash Flow: -30109000000.00
CVX balance_sheet (annual, 2023-12-31) — Finished Goods: 6465000000.00
CVX balance_sheet (annual, 2023-12-31) — Foreign Currency Translation Adjustments: -192000000.00
CVX cash_flow (annual, 2023-12-31) — Free Cash Flow: 19780000000.00
CVX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -3200000000.00
CVX balance_sheet (annual, 2023-12-31) — Goodwill: 4722000000.00
CVX balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 4722000000.00
CVX balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 20222000000.00
CVX balance_sheet (annual, 2023-12-31) — Gross PPE: 346081000000.00
CVX income_statement (annual, 2023-12-31) — Gross Profit: 60391000000.00
CVX cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 10416000000.00
CVX balance_sheet (annual, 2023-12-31) — Income Tax Payable: 1863000000.00
CVX income_statement (annual, 2023-12-31) — Interest Expense: 469000000.00
CVX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 469000000.00
CVX cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 465000000.00
CVX balance_sheet (annual, 2023-12-31) — Inventory: 8612000000.00
CVX balance_sheet (annual, 2023-12-31) — Invested Capital: 181159000000.00
CVX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -15232000000.00
CVX balance_sheet (annual, 2023-12-31) — Investments And Advances: 46812000000.00
CVX cash_flow (annual, 2023-12-31) — Issuance Of Debt: 285000000.00
CVX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 574000000.00
CVX balance_sheet (annual, 2023-12-31) — Long Term Debt: 19733000000.00
CVX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 20307000000.00
CVX cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 150000000.00
CVX cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -4340000000.00
CVX balance_sheet (annual, 2023-12-31) — Minimum Pension Liabilities: -3002000000.00
CVX balance_sheet (annual, 2023-12-31) — Minority Interest: 972000000.00
CVX income_statement (annual, 2023-12-31) — Minority Interests: -42000000.00
CVX cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 278000000.00
CVX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -14939000000.00
CVX balance_sheet (annual, 2023-12-31) — Net Debt: 12024000000.00
CVX cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 578000000.00
CVX income_statement (annual, 2023-12-31) — Net Income: 21369000000.00
CVX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 21369000000.00
CVX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 21411000000.00
CVX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 21369000000.00
CVX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 21369000000.00
CVX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 21411000000.00
CVX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 21411000000.00
CVX income_statement (annual, 2023-12-31) — Net Interest Income: -469000000.00
CVX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 175000000.00
CVX cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -4055000000.00
CVX cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -4190000000.00
CVX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -469000000.00
CVX cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -40000000.00
CVX cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 144000000.00
CVX balance_sheet (annual, 2023-12-31) — Net PPE: 153619000000.00
CVX cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 135000000.00
CVX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 156235000000.00
CVX balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 942000000.00
CVX balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 18830000000.00
CVX balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 18830000000.00
CVX income_statement (annual, 2023-12-31) — Normalized EBITDA: 47815000000.00
CVX income_statement (annual, 2023-12-31) — Normalized Income: 21369000000.00
CVX cash_flow (annual, 2023-12-31) — Operating Cash Flow: 35609000000.00
CVX cash_flow (annual, 2023-12-31) — Operating Gains Losses: -4553000000.00
CVX income_statement (annual, 2023-12-31) — Operating Income: 26229000000.00
CVX income_statement (annual, 2023-12-31) — Operating Revenue: 196913000000.00
CVX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 1851479804.00
CVX balance_sheet (annual, 2023-12-31) — Other Current Assets: 4372000000.00
CVX balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 469000000.00
CVX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 5000000.00
CVX income_statement (annual, 2023-12-31) — Other Income Expense: 3824000000.00
CVX cash_flow (annual, 2023-12-31) — Other Non Cash Items: -220000000.00
CVX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 14409000000.00
CVX balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 24226000000.00
CVX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -1307000000.00
CVX income_statement (annual, 2023-12-31) — Other Operating Expenses: 25801000000.00
CVX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 45000000.00
CVX income_statement (annual, 2023-12-31) — Other Taxes: 4220000000.00
CVX balance_sheet (annual, 2023-12-31) — Payables: 24074000000.00
CVX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 31729000000.00
CVX balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CVX income_statement (annual, 2023-12-31) — Pretax Income: 29584000000.00
CVX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 261000000.00
CVX cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CVX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -289000000.00
CVX balance_sheet (annual, 2023-12-31) — Raw Materials: 2147000000.00
CVX balance_sheet (annual, 2023-12-31) — Receivables: 19921000000.00
CVX income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 136522000000.00
CVX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 17762000000.00
CVX cash_flow (annual, 2023-12-31) — Repayment Of Debt: -4340000000.00
CVX cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -14939000000.00
CVX balance_sheet (annual, 2023-12-31) — Retained Earnings: 200025000000.00
CVX cash_flow (annual, 2023-12-31) — Sale Of Business: 278000000.00
CVX cash_flow (annual, 2023-12-31) — Sale Of Investment: 464000000.00
CVX income_statement (annual, 2023-12-31) — Selling General And Administration: 4141000000.00
CVX balance_sheet (annual, 2023-12-31) — Share Issued: 2442676580.00
CVX cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 135000000.00
CVX cash_flow (annual, 2023-12-31) — Short Term Debt Payments: 0.00
CVX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 160957000000.00
CVX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 156235000000.00
CVX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CVX income_statement (annual, 2023-12-31) — Tax Provision: 8173000000.00
CVX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.28
CVX balance_sheet (annual, 2023-12-31) — Total Assets: 261632000000.00
CVX balance_sheet (annual, 2023-12-31) — Total Capitalization: 180690000000.00
CVX balance_sheet (annual, 2023-12-31) — Total Debt: 20836000000.00
CVX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 161929000000.00
CVX income_statement (annual, 2023-12-31) — Total Expenses: 170684000000.00
CVX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 99703000000.00
CVX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 220504000000.00
CVX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 67445000000.00
CVX balance_sheet (annual, 2023-12-31) — Total Tax Payable: 3651000000.00
CVX balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 591196776.00
CVX balance_sheet (annual, 2023-12-31) — Treasury Stock: 59065000000.00
CVX balance_sheet (annual, 2023-12-31) — Unrealized Gain Loss: -11000000.00
CVX balance_sheet (annual, 2023-12-31) — Working Capital: 8870000000.00
CVX balance_sheet (quarterly, 2024-09-30) — Foreign Currency Translation Adjustments: -201000000.00
CVX balance_sheet (quarterly, 2024-09-30) — Unrealized Gain Loss: -16000000.00
CVX income_statement (annual, 2024-12-31) — +Operating Expense: 38009000000.00
CVX income_statement (annual, 2024-12-31) — +Total Revenue: 193414000000.00
CVX balance_sheet (annual, 2024-12-31) — Accounts Payable: 22079000000.00
CVX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 20684000000.00
CVX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -198134000000.00
CVX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 21671000000.00
CVX balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -259000000.00
CVX cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 500000000.00
CVX income_statement (annual, 2024-12-31) — Basic Average Shares: 1809583000.00
CVX income_statement (annual, 2024-12-31) — Basic EPS: 9.76
CVX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 9275000000.00
CVX cash_flow (annual, 2024-12-31) — Capital Expenditure: -16448000000.00
CVX cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -16448000000.00
CVX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 604000000.00
CVX balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 604000000.00
CVX balance_sheet (annual, 2024-12-31) — Capital Stock: 1832000000.00
CVX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 6781000000.00
CVX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 6785000000.00
CVX cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -11801000000.00
CVX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -23472000000.00
CVX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -8936000000.00
CVX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 31492000000.00
CVX cash_flow (annual, 2024-12-31) — Change In Account Payable: 2569000000.00
CVX cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: 164000000.00
CVX cash_flow (annual, 2024-12-31) — Change In Inventory: -574000000.00
CVX cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -1225000000.00
CVX cash_flow (annual, 2024-12-31) — Change In Payable: 2733000000.00
CVX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 2733000000.00
CVX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -16000000.00
CVX cash_flow (annual, 2024-12-31) — Change In Receivables: -818000000.00
CVX cash_flow (annual, 2024-12-31) — Change In Tax Payable: 164000000.00
CVX cash_flow (annual, 2024-12-31) — Change In Working Capital: 100000000.00
CVX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -932000000.00
CVX cash_flow (annual, 2024-12-31) — Changes In Cash: -916000000.00
CVX balance_sheet (annual, 2024-12-31) — Common Stock: 1832000000.00
CVX cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -11801000000.00
CVX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 152318000000.00
CVX cash_flow (annual, 2024-12-31) — Common Stock Payments: -15229000000.00
CVX income_statement (annual, 2024-12-31) — Cost Of Revenue: 136488000000.00
CVX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 8486000000.00
CVX balance_sheet (annual, 2024-12-31) — Current Assets: 40911000000.00
CVX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 58000000.00
CVX balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 58000000.00
CVX balance_sheet (annual, 2024-12-31) — Current Debt: 4348000000.00
CVX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 4406000000.00
CVX balance_sheet (annual, 2024-12-31) — Current Liabilities: 38558000000.00
CVX cash_flow (annual, 2024-12-31) — Deferred Income Tax: 1240000000.00
CVX cash_flow (annual, 2024-12-31) — Deferred Tax: 1240000000.00
CVX cash_flow (annual, 2024-12-31) — Depletion: 429000000.00
CVX cash_flow (annual, 2024-12-31) — Depreciation: 17282000000.00
CVX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 17711000000.00
CVX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 17282000000.00
CVX income_statement (annual, 2024-12-31) — Diluted Average Shares: 1816602000.00
CVX income_statement (annual, 2024-12-31) — Diluted EPS: 9.72
CVX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 17661000000.00
CVX cash_flow (annual, 2024-12-31) — Dividend Received Cfo: 4230000000.00
CVX income_statement (annual, 2024-12-31) — EBIT: 28100000000.00
CVX income_statement (annual, 2024-12-31) — EBITDA: 45811000000.00
CVX income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 4596000000.00
CVX cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: -4596000000.00
CVX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -97000000.00
CVX balance_sheet (annual, 2024-12-31) — Employee Benefits: 3857000000.00
CVX cash_flow (annual, 2024-12-31) — End Cash Position: 8262000000.00
CVX cash_flow (annual, 2024-12-31) — Financing Cash Flow: -23472000000.00
CVX balance_sheet (annual, 2024-12-31) — Finished Goods: 6992000000.00
CVX balance_sheet (annual, 2024-12-31) — Foreign Currency Translation Adjustments: -259000000.00
CVX balance_sheet (quarterly, 2024-12-31) — Foreign Currency Translation Adjustments: -259000000.00
CVX cash_flow (annual, 2024-12-31) — Free Cash Flow: 15044000000.00
CVX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -3000000000.00
CVX balance_sheet (annual, 2024-12-31) — Goodwill: 4578000000.00
CVX balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 4578000000.00
CVX balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 20943000000.00
CVX balance_sheet (annual, 2024-12-31) — Gross PPE: 345933000000.00
CVX income_statement (annual, 2024-12-31) — Gross Profit: 56926000000.00
CVX cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 8458000000.00
CVX balance_sheet (annual, 2024-12-31) — Income Tax Payable: 1872000000.00
CVX income_statement (annual, 2024-12-31) — Interest Expense: 594000000.00
CVX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 594000000.00
CVX cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 587000000.00
CVX balance_sheet (annual, 2024-12-31) — Inventory: 9074000000.00
CVX balance_sheet (annual, 2024-12-31) — Invested Capital: 176255000000.00
CVX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -8936000000.00
CVX balance_sheet (annual, 2024-12-31) — Investments And Advances: 47438000000.00
CVX cash_flow (annual, 2024-12-31) — Issuance Of Debt: 6186000000.00
CVX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 546000000.00
CVX balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 546000000.00
CVX balance_sheet (annual, 2024-12-31) — Long Term Debt: 19589000000.00
CVX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 20135000000.00
CVX cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 478000000.00
CVX cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -1778000000.00
CVX balance_sheet (annual, 2024-12-31) — Minimum Pension Liabilities: -2708000000.00
CVX balance_sheet (annual, 2024-12-31) — Minority Interest: 839000000.00
CVX income_statement (annual, 2024-12-31) — Minority Interests: -88000000.00
CVX cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 195000000.00
CVX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -15229000000.00
CVX balance_sheet (annual, 2024-12-31) — Net Debt: 17156000000.00
CVX cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -629000000.00
CVX income_statement (annual, 2024-12-31) — Net Income: 17661000000.00
CVX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 17661000000.00
CVX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 17749000000.00
CVX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 17661000000.00
CVX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 17661000000.00
CVX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 17749000000.00
CVX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 17749000000.00
CVX income_statement (annual, 2024-12-31) — Net Interest Income: -594000000.00
CVX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 41000000.00
CVX cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
CVX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 3568000000.00
CVX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -1300000000.00
CVX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -594000000.00
CVX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -340000000.00
CVX cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 7276000000.00
CVX balance_sheet (annual, 2024-12-31) — Net PPE: 147799000000.00
CVX cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 4868000000.00
CVX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 147740000000.00
CVX balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 877000000.00
CVX balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 19137000000.00
CVX balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 19137000000.00
CVX income_statement (annual, 2024-12-31) — Normalized EBITDA: 45811000000.00
CVX income_statement (annual, 2024-12-31) — Normalized Income: 17661000000.00
CVX cash_flow (annual, 2024-12-31) — Operating Cash Flow: 31492000000.00
CVX cash_flow (annual, 2024-12-31) — Operating Gains Losses: -5225000000.00
CVX income_statement (annual, 2024-12-31) — Operating Income: 18917000000.00
CVX income_statement (annual, 2024-12-31) — Operating Revenue: 193414000000.00
CVX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 1769012274.00
CVX balance_sheet (annual, 2024-12-31) — Other Current Assets: 4368000000.00
CVX balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 4348000000.00
CVX balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 4348000000.00
CVX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -14000000.00
CVX income_statement (annual, 2024-12-31) — Other Income Expense: 9183000000.00
CVX cash_flow (annual, 2024-12-31) — Other Non Cash Items: -4313000000.00
CVX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 15335000000.00
CVX balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 22094000000.00
CVX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 4587000000.00
CVX income_statement (annual, 2024-12-31) — Other Operating Expenses: 28459000000.00
CVX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 4000000.00
CVX income_statement (annual, 2024-12-31) — Other Taxes: 4716000000.00
CVX balance_sheet (annual, 2024-12-31) — Payables: 25666000000.00
CVX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 34152000000.00
CVX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CVX income_statement (annual, 2024-12-31) — Pretax Income: 27506000000.00
CVX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 330000000.00
CVX cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
CVX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -6000000.00
CVX cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -2000000.00
CVX balance_sheet (annual, 2024-12-31) — Raw Materials: 2082000000.00
CVX balance_sheet (annual, 2024-12-31) — Receivables: 20684000000.00
CVX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 136488000000.00
CVX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 17711000000.00
CVX cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2618000000.00
CVX cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -15229000000.00
CVX balance_sheet (annual, 2024-12-31) — Retained Earnings: 205852000000.00
CVX cash_flow (annual, 2024-12-31) — Sale Of Business: 195000000.00
CVX cash_flow (annual, 2024-12-31) — Sale Of Investment: 47000000.00
CVX cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 2000000.00
CVX income_statement (annual, 2024-12-31) — Selling General And Administration: 4834000000.00
CVX balance_sheet (annual, 2024-12-31) — Share Issued: 2442676580.00
CVX cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 5708000000.00
CVX cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -840000000.00
CVX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 152318000000.00
CVX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 147740000000.00
CVX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CVX income_statement (annual, 2024-12-31) — Tax Provision: 9757000000.00
CVX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.36
CVX balance_sheet (annual, 2024-12-31) — Total Assets: 256938000000.00
CVX balance_sheet (annual, 2024-12-31) — Total Capitalization: 171907000000.00
CVX balance_sheet (annual, 2024-12-31) — Total Debt: 24541000000.00
CVX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 153157000000.00
CVX income_statement (annual, 2024-12-31) — Total Expenses: 174497000000.00
CVX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 103781000000.00
CVX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 216027000000.00
CVX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 65223000000.00
CVX balance_sheet (annual, 2024-12-31) — Total Tax Payable: 3587000000.00
CVX balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 673664306.00
CVX balance_sheet (annual, 2024-12-31) — Treasury Stock: 74037000000.00
CVX balance_sheet (annual, 2024-12-31) — Unrealized Gain Loss: -19000000.00
CVX balance_sheet (quarterly, 2024-12-31) — Unrealized Gain Loss: -19000000.00
CVX balance_sheet (annual, 2024-12-31) — Working Capital: 2353000000.00
CVX income_statement (quarterly, 2025-03-31) — +Operating Expense: 9071000000.00
CVX income_statement (quarterly, 2025-03-31) — +Total Revenue: 46101000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 20878000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 19560000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -200696000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 21719000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -240000000.00
CVX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 1744628000.00
CVX income_statement (quarterly, 2025-03-31) — Basic EPS: 2.01
CVX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 8262000000.00
CVX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -3927000000.00
CVX cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -3927000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1832000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4638000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4643000000.00
CVX cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -2984000000.00
CVX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1664000000.00
CVX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -5618000000.00
CVX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 5189000000.00
CVX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1307000000.00
CVX cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: -1268000000.00
CVX cash_flow (quarterly, 2025-03-31) — Change In Inventory: -201000000.00
CVX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -172000000.00
CVX cash_flow (quarterly, 2025-03-31) — Change In Payable: -2575000000.00
CVX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -2575000000.00
CVX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -769000000.00
CVX cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1097000000.00
CVX cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: -1268000000.00
CVX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -2620000000.00
CVX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1137000000.00
CVX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -2093000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Common Stock: 1832000000.00
CVX cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -2984000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 149244000000.00
CVX cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -3917000000.00
CVX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 32733000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 8374000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Current Assets: 38574000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Current Debt: 4076000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4076000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 35702000000.00
CVX cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 480000000.00
CVX cash_flow (quarterly, 2025-03-31) — Deferred Tax: 480000000.00
CVX cash_flow (quarterly, 2025-03-31) — Depletion: 112000000.00
CVX cash_flow (quarterly, 2025-03-31) — Depreciation: 4123000000.00
CVX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 4235000000.00
CVX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 4123000000.00
CVX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 1751441000.00
CVX income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.00
CVX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 3500000000.00
CVX cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 1088000000.00
CVX income_statement (quarterly, 2025-03-31) — EBIT: 5795000000.00
CVX income_statement (quarterly, 2025-03-31) — EBITDA: 10030000000.00
CVX income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 820000000.00
CVX cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -820000000.00
CVX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -3000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 3806000000.00
CVX cash_flow (quarterly, 2025-03-31) — End Cash Position: 6166000000.00
CVX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1664000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Finished Goods: 7071000000.00
CVX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 1262000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -2949000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Goodwill: 4568000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 4568000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 19800000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 348820000000.00
CVX income_statement (quarterly, 2025-03-31) — Gross Profit: 13368000000.00
CVX cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 2552000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 842000000.00
CVX income_statement (quarterly, 2025-03-31) — Interest Expense: 212000000.00
CVX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 212000000.00
CVX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 124000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Inventory: 9167000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 178925000000.00
CVX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -5618000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 49150000000.00
CVX cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 7808000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 25605000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 25605000000.00
CVX cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 5491000000.00
CVX cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -61000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Minimum Pension Liabilities: -240000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Minority Interest: 836000000.00
CVX income_statement (quarterly, 2025-03-31) — Minority Interests: -12000000.00
CVX cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -2218000000.00
CVX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -3917000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Net Debt: 25043000000.00
CVX cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 130000000.00
CVX income_statement (quarterly, 2025-03-31) — Net Income: 3500000000.00
CVX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 3500000000.00
CVX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 3512000000.00
CVX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 3500000000.00
CVX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 3500000000.00
CVX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 3512000000.00
CVX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 3512000000.00
CVX income_statement (quarterly, 2025-03-31) — Net Interest Income: -212000000.00
CVX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
CVX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 5030000000.00
CVX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 5430000000.00
CVX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -212000000.00
CVX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -11000000.00
CVX cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 527000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Net PPE: 148124000000.00
CVX cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -400000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 144676000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 942000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 19594000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 19594000000.00
CVX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 10030000000.00
CVX income_statement (quarterly, 2025-03-31) — Normalized Income: 3500000000.00
CVX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 5189000000.00
CVX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -690000000.00
CVX income_statement (quarterly, 2025-03-31) — Operating Income: 4297000000.00
CVX income_statement (quarterly, 2025-03-31) — Operating Revenue: 46101000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1732000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 5204000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -2709000000.00
CVX income_statement (quarterly, 2025-03-31) — Other Income Expense: 1498000000.00
CVX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -816000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 15039000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 21610000000.00
CVX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 678000000.00
CVX income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 6595000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 5000000.00
CVX income_statement (quarterly, 2025-03-31) — Other Taxes: 1255000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Payables: 23252000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 31626000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CVX income_statement (quarterly, 2025-03-31) — Pretax Income: 5583000000.00
CVX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 218000000.00
CVX cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -2225000000.00
CVX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
CVX balance_sheet (quarterly, 2025-03-31) — Raw Materials: 2096000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Receivables: 19560000000.00
CVX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 32733000000.00
CVX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 4235000000.00
CVX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -2778000000.00
CVX cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -3917000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 206359000000.00
CVX cash_flow (quarterly, 2025-03-31) — Sale Of Business: 7000000.00
CVX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
CVX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1221000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Share Issued: 2442450675.00
CVX cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 2317000000.00
CVX cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -2717000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 149244000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 144676000000.00
CVX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CVX income_statement (quarterly, 2025-03-31) — Tax Provision: 2071000000.00
CVX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.37
CVX balance_sheet (quarterly, 2025-03-31) — Total Assets: 256397000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 174849000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Total Debt: 29681000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 150080000000.00
CVX income_statement (quarterly, 2025-03-31) — Total Expenses: 41804000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 106317000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 217823000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 70615000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 2374000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 710450675.00
CVX balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 77717000000.00
CVX balance_sheet (quarterly, 2025-03-31) — Working Capital: 2872000000.00
CVX income_statement (quarterly, 2025-06-30) — +Operating Expense: 9116000000.00
CVX income_statement (quarterly, 2025-06-30) — +Total Revenue: 44375000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 18609000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 17663000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -204593000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 21803000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -188000000.00
CVX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 1719184000.00
CVX income_statement (quarterly, 2025-06-30) — Basic EPS: 1.45
CVX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 6166000000.00
CVX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3712000000.00
CVX cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -3712000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1832000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 4061000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 4066000000.00
CVX cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -2934000000.00
CVX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -5985000000.00
CVX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -3432000000.00
CVX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 8576000000.00
CVX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -2655000000.00
CVX cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -356000000.00
CVX cash_flow (quarterly, 2025-06-30) — Change In Inventory: 354000000.00
CVX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -55000000.00
CVX cash_flow (quarterly, 2025-06-30) — Change In Payable: -3011000000.00